These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26484904)

  • 41. Genetic algorithm-based PCA eigenvector selection and weighting for automated identification of dementia using FDG-PET imaging.
    Xia Y; Wen L; Eberl S; Fulham M; Feng D
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():4812-5. PubMed ID: 19163793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of whole-body ¹⁸F-fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer.
    Heo EY; Yang SC; Yoo CG; Han SK; Shim YS; Kim YW
    Respirology; 2010 Nov; 15(8):1174-8. PubMed ID: 20573060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
    Flechsig P; Kratochwil C; Schwartz LH; Rath D; Moltz J; Antoch G; Heussel CP; Rieser M; Warth A; Zabeck H; Kauczor HU; Haberkorn U; Giesel FL
    J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
    Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia.
    Garibotto V; Montandon ML; Viaud CT; Allaoua M; Assal F; Burkhard PR; Ratib O; Zaidi H
    Clin Nucl Med; 2013 Mar; 38(3):e112-7. PubMed ID: 23357822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.
    Morbelli S; Garibotto V; Van De Giessen E; Arbizu J; Chételat G; Drezgza A; Hesse S; Lammertsma AA; Law I; Pappata' S; Payoux P; Pagani M;
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1487-91. PubMed ID: 26067090
    [No Abstract]   [Full Text] [Related]  

  • 49. MR-based attenuation correction using ultrashort-echo-time pulse sequences in dementia patients.
    Cabello J; Lukas M; Förster S; Pyka T; Nekolla SG; Ziegler SI
    J Nucl Med; 2015 Mar; 56(3):423-9. PubMed ID: 25678486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis.
    Hungenbach S; Delank KS; Dietlein M; Eysel P; Drzezga A; Schmidt MC
    Nucl Med Commun; 2013 Nov; 34(11):1068-74. PubMed ID: 24025917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
    Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.
    Yamada I; Ajiki T; Ueno K; Sawa H; Otsubo I; Yoshida Y; Shinzeki M; Toyama H; Matsumoto I; Fukumoto T; Nakao A; Kotani J; Ku Y
    Anticancer Res; 2012 Nov; 32(11):5105-10. PubMed ID: 23155288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
    Jolepalem P; Balon HR; Wong CY; Wu D
    J Nucl Med Technol; 2014 Sep; 42(3):233-4. PubMed ID: 25033885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of initial 18F-fluorodeoxyglucose-positron emission tomography indication among patients with colorectal cancer.
    Zafar HM; Kramer S; Bonaccorsi D; Langlotz CP; Armstrong K
    Nucl Med Commun; 2012 Jul; 33(7):739-46. PubMed ID: 22531828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
    Hart DP; Avivi I; Thomson KJ; Peggs KS; Morris EC; Goldstone AH; Linch DC; Ell PJ; Bomanji JB; Mackinnon S
    Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.